These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 7997759)

  • 21. The rapid fluorescent focus inhibition test is a suitable method for batch potency testing of inactivated rabies vaccines.
    Krämer B; Schildger H; Behrensdorf-Nicol HA; Hanschmann KM; Duchow K
    Biologicals; 2009 Apr; 37(2):119-26. PubMed ID: 19181541
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Evaluation of the usefulness of the antibody binding test for the estimation of the potency of the rabies vaccine].
    Wysokińska T; Janaszek W; Rymkiewicz D
    Przegl Epidemiol; 1994; 48(3):297-9. PubMed ID: 7938635
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Questions concerning the potency of rabies vaccine.
    Crick J; Brown F
    Dev Biol Stand; 1978; 40():179-82. PubMed ID: 355012
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of competitive inhibition ELISA as an effective potency test to analyze human rabies vaccines and assessment of the antigenic epitope of rabies glycoprotein.
    Soni D; Sahoo I; Mallya AD; Kamthe P; Sahai A; Goel SK; Kulkarni PS; Dhere RM
    J Immunol Methods; 2021 May; 492():112939. PubMed ID: 33309752
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development and evaluation of a competitive ELISA for estimation of rabies neutralizing antibodies after post-exposure rabies vaccination in humans.
    Muhamuda K; Madhusudana SN; Ravi V
    Int J Infect Dis; 2007 Sep; 11(5):441-5. PubMed ID: 17321182
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A relevant in vitro ELISA test in alternative to the in vivo NIH test for human rabies vaccine batch release.
    Gibert R; Alberti M; Poirier B; Jallet C; Tordo N; Morgeaux S
    Vaccine; 2013 Dec; 31(50):6022-9. PubMed ID: 24161572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rabies deaths in Pakistan: results of ineffective post-exposure treatment.
    Parviz S; Chotani R; McCormick J; Fisher-Hoch S; Luby S
    Int J Infect Dis; 2004 Nov; 8(6):346-52. PubMed ID: 15494256
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of an animal rabies vaccine by use of two types of potency tests.
    Baer GM
    Am J Vet Res; 1997 Aug; 58(8):837-40. PubMed ID: 9256966
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alternatives for potency testing of veterinary vaccines: rabies vaccine as a model.
    Bruckner L; Kihm U
    Dev Biol Stand; 1986; 64():93-7. PubMed ID: 3792660
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rabies cell culture vaccines reconstituted and stored at 4 degrees C for 1 year prior to use protect mice against rabies virus.
    Lodmell DL; Ewalt LC
    Vaccine; 2004 Sep; 22(25-26):3237-9. PubMed ID: 15308344
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A simple immuno-capture ELISA to estimate rabies viral glycoprotein antigen in vaccine manufacture.
    Nagarajan T; Reddy GS; Mohana Subramanian B; Rajalakshmi S; Thiagarajan D; Tordo N; Jallet C; Srinivasan VA
    Biologicals; 2006 Mar; 34(1):21-7. PubMed ID: 16188454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validation of an in vitro assay for the determination of rabies antigen.
    Barth R; Gruschkau H; Milcke L; Jaeger O; Weinmann E
    Dev Biol Stand; 1986; 64():87-92. PubMed ID: 3792659
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Humoral immunity conferred by the HDCS rabies vaccine Mérieux administered after exposure: 151 cases with and without specific immune globulin of human origin. Preliminary communication.
    Méan F; Steck F; Tanner F
    Dev Biol Stand; 1978; 40():159-61. PubMed ID: 680389
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of rabies virus antigen or antibody using flow cytometry.
    Vengatesan D; Raj GD; Raja A; Ramadass P; Gunaseelan L
    Cytometry B Clin Cytom; 2006 Sep; 70(5):335-43. PubMed ID: 16739219
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Influence of aluminum adjuvant to experimental rabies vaccine].
    Lin H; Perrin P
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1999 Jun; 13(2):133-5. PubMed ID: 12569779
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Zonal centrifuge purification of human rabies vaccine obtained on bovine fetal kidney cells. Biological results.
    Atanasiu P; Tsiang H; Reculard P; Aguilon F; Lavergne M; Adamovicz P
    Dev Biol Stand; 1978; 40():35-44. PubMed ID: 680400
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Establishment of a potency test by ELISA for a rabies vaccine for animal use in Japan.
    Gamoh K; Shimazaki Y; Senda M; Makie H; Itoh O; Muramatsu M; Hirayama N; Hatakeyama H
    J Vet Med Sci; 2003 Jun; 65(6):685-8. PubMed ID: 12867727
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A purified human diploid cell rabies vaccine.
    Majer M; Hilfenhaus J; Gruschkau H; Mauler R; Hennessen W
    Dev Biol Stand; 1978; 40():25-8. PubMed ID: 680396
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies on candidate reference preparations of rabies vaccine.
    Wiktor TJ; Boegel K; Cox JH; Diaz AM; Fitzgerald E; Netter R; Turner G; Schneider LG; van Steenis G
    Dev Biol Stand; 1978; 40():187-93. PubMed ID: 355014
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [NIH potency tests with inactivated rabies vaccines (author's transl)].
    Barth R; Jaeger O
    Zentralbl Bakteriol B; 1979; 169(5-6):488-94. PubMed ID: 545949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.